PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay

Cimadamore, A; Massari, F; Santoni, M; Lopez-Beltran, A; Cheng, L; Scarpelli, M; Montironi, R; Moch, H

Cimadamore, A (corresponding author), Polytech Univ Marche Reg, United Hosp, Sch Med, Sect Pathol Anat, Via Conca 71, I-60126 Ancona, Italy.

CURRENT DRUG TARGETS, 2020; 21 (16): 1664

Abstract

Background: Immune checkpoint inhibitors targeting the programmed death receptor ligand 1 (PD-L1)/programmed death receptor 1 (PD-1) pathway represent......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索